Personality Traits, Psychological Stress, and Anatomical Biomarkers in Central Serous Chorioretinopathy: A Multimodal Case–Control Study
Abstract
Background: To investigate the anatomical and psychological characteristics of Central Serous Chorioretinopathy (CSCR) using a multimodal approach combining spectral-domain optical coherence tomography (OCT) and psychometric profiling. The study aims to explore potential correlations between personality traits and disease features to inform future risk stratification and management.
Methods: A case–control observational study involving 44 participants (22 patients with CSCR and 22 age- and sex-matched healthy controls). Participants underwent high-resolution OCT to assess choroidal thickness, subretinal fluid, and photoreceptor integrity. Psychological profiles were evaluated using the Personality Inventory for DSM-5–Brief Form (PID-5-BF) and the Temperament Evaluation of Memphis, Pisa, Paris, and San Diego–Brief (TEMPS-A-brief). Data were statistically analyzed using Python 3.11, with significance set at p < 0.05.
Results: CSCR was more prevalent in males (male:female ratio of 10:1), with a mean age of 50.6 years. OCT revealed increased choroidal thickness, photoreceptor disruption, and subretinal fluid in affected individuals. A positive correlation was found between age and choroidal thickness (ρ = 0.41; p < 0.05). No significant association was found with corticosteroid use. Although group comparisons in psychological traits were not statistically significant, a trend toward elevated negative affectivity was observed in the CSCR group.
Conclusions: CSCR appears to result from a multifactorial interaction between anatomical and psychological components. While no definitive psychological markers were identified, elevated negative affectivity may serve as a vulnerability trait in susceptible individuals. Further longitudinal and larger-scale studies are necessary to validate these findings and investigate the utility of psychological screening in CSCR care.
Keywords
Full Text:
PDFReferences
Agorastos, A., & Chrousos, G. P. (2022). The neuroendocrinology of stress: the stress-related continuum of chronic disease development. Molecular psychiatry, 27(1), 502-513. https://doi.org/10.1038/s41380-021-01224-9
Akiskal, H. S., Mendlowicz, M. V., Jean-Louis, G., Rapaport, M. H., Kelsoe, J. R., Gillin, J. C., & Smith, T. L. (2005). TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament. Journal of affective disorders, 85(1-2), 45–52. https://doi.org/10.1016/j.jad.2003.10.012
Akyirem, S., Forbes, A., Wad, J. L., & Due-Christensen, M. (2022). Psychosocial interventions for adults with newly diagnosed chronic disease: a systematic review. Journal of Health Psychology, 27(7), 1753-1782. https://doi.org/10.1177/1359105321995916
Anderson, J. L., Sellbom, M., & Salekin, R. T. (2018). Utility of the Personality Inventory for DSM-5–Brief Form (PID-5-BF) in the measurement of maladaptive personality and psychopathology. Assessment, 25(5), 596-607. https://doi.org/10.1177/1073191116676889
Bach, B., Maples-Keller, J. L., Bo, S., & Simonsen, E. (2016). The alternative DSM–5 personality disorder traits criterion: A comparative examination of three self-report forms in a Danish population. Personality Disorders: Theory, Research, and Treatment, 7(2), 124. https://doi.org/10.1037/per0000162
Bazzazi, N., Ahmadpanah, M., Akbarzadeh, S., Seif Rabiei, M. A., Holsboer-Trachsler, E., & Brand, S. (2015). In patients suffering from idiopathic central serous chorioretinopathy, anxiety scores are higher than in healthy controls, but do not vary according to sex or repeated central serous chorioretinopathy. Neuropsychiatric disease and treatment, 1131-1136. https://doi.org/10.2147/NDT.S83216
Berger, L., Bühler, V., & Yzer, S. (2021). Central serous chorioretinopathy–An overview. Klinische Monatsblätter für Augenheilkunde, 238(09), 971-979. https://doi.org/10.1055/a-1531-5605
Bespalov, A., Steckler, T., & Skolnick, P. (2019). Be positive about negatives–recommendations for the publication of negative (or null) results. European Neuropsychopharmacology, 29(12), 1312-1320. https://doi.org/10.1016/j.euroneuro.2019.10.007
Bousquet, E., Torres-Villaros, H., Provost, J., Elalouf, M., Gigon, A., Mantel, I., Timsit, A., & Behar-Cohen, F. (2022). Clinical characteristics and multimodal imaging findings of central serous chorioretinopathy in women versus men. Journal of clinical medicine, 11(6), 1706. https://doi.org/10.3390/jcm11061706
Brar, M. K., & Brar, A. S. (2024). Concerns and observations on “Association of central serous chorioretinopathy with type of personality, anxiety and depression”. Indian Journal of Ophthalmology, 72(Suppl 4), S715-S716. https://doi.org/10.4103/IJO.IJO_298_24
Brown, R., Sahoo, N. K., Ong, J., Selvam, A., Avdalimov, M., Kulkarni, A., Hansraj, S., Gujar, R., Arora, S., Singh, S. R., Lupidi, M., Zur, D., & Chhablani, J. (2023). Gender differences in central serous chorioretinopathy based on new multimodal imaging classification. Investigative Ophthalmology & Visual Science, 64(8), 4626-4626.
Cacha, L. A., Poznanski, R. R., Latif, A. Z., & Ariff, T. M. (2019). Psychophysiology of chronic stress: An example of mind-body interaction. NeuroQuantology, 17(07), 53-63. https://doi.org/10.14704/nq.2019.17.7.2562
Çam, F., Sevik, M. O., Aykut, A., Dericioğlu, V., Çam, C. Ş., & Şahin, Ö. (2024). Dysfunctional personality beliefs and psychopathology in patients with central serous chorioretinopathy. Journal francais d'ophtalmologie, 47(2), 103997. https://doi.org/10.1016/j.jfo.2023.05.032
Castelnuovo, G., Zoppis, I., Santoro, E., Ceccarini, M., Pietrabissa, G., Manzoni, G. M., Corti, S., Borrello, M., Giusti, E. M., Cattivelli, R., Malesi, A., Mauri, G., Molinari, E., & Sicurello, F. (2015). Managing chronic pathologies with a stepped mHealth-based approach in clinical psychology and medicine. Frontiers in psychology, 6, 407. https://doi.org/10.3389/fpsyg.2015.00407
Ceruso, A., Martínez-Cengotitabengoa, M., Peters-Corbett, A., Diaz-Gutierrez, M. J., & Martínez-Cengotitabengoa, M. (2020). Alterations of the HPA axis observed in patients with major depressive disorder and their relation to early life stress: a systematic review. Neuropsychobiology, 79(6), 417-427. https://doi.org/10.1159/000506484
Çiloğlu, E., Unal, F., & Dogan, N. C. (2018). The relationship between the central serous chorioretinopathy, choroidal thickness, and serum hormone levels. Graefe's Archive for Clinical and Experimental Ophthalmology, 256(6), 1111-1116. https://doi.org/10.1007/s00417-018-3985-x
Combaluzier, S., Gouvernet, B., Menant, F., & Rezrazi, A. (2016). Validation of a French translation of Krueger's personality inventory for DSM-5 in its brief form (PID-5 BF). L'encephale, 44(1), 9-13. https://doi.org/10.1016/j.encep.2016.07.006
Conrad, R., Geiser, F., Kleiman, A., Zur, B., & Karpawitz-Godt, A. (2014). Temperament and character personality profile and illness‐related stress in central serous chorioretinopathy. The Scientific World Journal, 2014(1), 631687. https://doi.org/10.1155/2014/631687
Conversano, C. (2019). Common psychological factors in chronic diseases. Frontiers in psychology, 10, 2727. https://doi.org/10.3389/fpsyg.2019.02727
Daruich, A., Matet, A., Dirani, A., Bousquet, E., Zhao, M., Farman, N., Jaisser, F., & Behar-Cohen, F. (2015). Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Progress in retinal and eye research, 48, 82-118. https://doi.org/10.1016/j.preteyeres.2015.05.003
De Ridder, D., Geenen, R., Kuijer, R., & Van Middendorp, H. (2008). Psychological adjustment to chronic disease. The Lancet, 372(9634), 246-255. https://doi.org/10.1016/S0140-6736(08)61078-8
Di Giuseppe, M., & Conversano, C. (2022). Psychological components of chronic diseases: the link between defense mechanisms and alexithymia. Mediterranean Journal of Clinical Psychology, 10(3). https://doi.org/10.13129/2282-1619/mjcp-3602
Dudani, A. I., Dudani, A. A., Dudani, K., & Dudani, A. A. (2024). Anxiolytic therapy for central serous chorioretinopaty patients suffering from anxiety and depression. Indian Journal of Ophthalmology, 72(10), 1529-1530. https://doi.org/10.4103/IJO.IJO_251_24
Dybała, E., Dybała-Przygrodzka, I., Cuber, I., Mazurek, M., Białowąs, E., & Aghadi, A. (2023). Central Serous Chorioretinopathy or a stressful lifestyle predisposes to the disease?-review of the current literature. Journal of Education, Health and Sport, 13(3), 252-261. https://doi.org/10.12775/JEHS.2023.13.03.034
Fossati, A., Somma, A., Borroni, S., Markon, K. E., & Krueger, R. F. (2017). The Personality Inventory for DSM-5 Brief Form: Evidence for reliability and construct validity in a sample of community-dwelling Italian adolescents. Assessment, 24(5), 615-631. https://doi.org/10.1177/1073191115621793
Fung, A. T., Yang, Y., & Kam, A. W. (2023). Central serous chorioretinopathy: a review. Clinical & experimental ophthalmology, 51(3), 243-270. https://doi.org/10.1111/ceo.14201
Gemenetzi, M., De Salvo, G., & Lotery, A. J. (2010). Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye, 24(12), 1743-1756. https://doi.org/10.1038/eye.2010.130
Genovese, G., Meduri, A., Muscatello, M. R. A., Gangemi, S., Cedro, C., Bruno, A., Aragona, P., & Pandolfo, G. (2021). Central serous chorioretinopathy and personality characteristics: a systematic review of scientific evidence over the last 10 years (2010 to 2020). Medicina, 57(6), 628. https://doi.org/10.3390/medicina57060628
Hyatt, C. S., Maples-Keller, J. L., Crowe, M. L., Sleep, C. E., Carter, S. T., Michopoulos, V., Stevens, J. S., Javanovic, T., Bradley, B., Miller, J. M., & Powers, A. (2021). Psychometric properties of the personality inventory for DSM-5-brief form in a community sample with high rates of trauma exposure. Journal of personality assessment, 103(2), 204-213. https://doi.org/10.1080/00223891.2020.1713138
Jain, M., Mohan, S., & van Dijk, E. H. (2022). Central serous chorioretinopathy: Pathophysiology, systemic associations, and a novel etiological classification. Taiwan Journal of Ophthalmology, 12(4), 381-393. https://doi.org/10.4103/2211-5056.362601
Jiakponna, E. C., Agbomola, J. O., Ipede, O., Karakitie, L., Ogunsina, A. J., Adebayo, K. T., & Tinuoye, M. O. (2024). Psychosocial factors in chronic disease management: implications for health psychology. International Journal of Science and Research Archive, 12(2), 117-128.
Kanda, P., Gupta, A., Gottlieb, C., Karanjia, R., Coupland, S. G., & Bal, M. S. (2022). Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment. Eye, 36(5), 941-962. https://doi.org/10.1038/s41433-021-01808-3
Kang, H. G., Woo, S. J., Lee, J. Y., Cho, H. J., Ahn, J., Yang, Y. S., Jo, Y.-J., Kim, S.-W., Kim, S. J., Sagong, M., Lee, J. J., Kang, M., Park, H. S., Byeon, S. H., Kim, S. S., Kang, S. W., Park, S. H., Kim, S. S., Kang, S. W., … & Lee, C. S. (2022). Pathogenic risk factors and associated outcomes in the bullous variant of central serous chorioretinopathy. Ophthalmology Retina, 6(10), 939-948. https://doi.org/10.1016/j.oret.2022.04.015
Koizumi, H., Imanaga, N., & Terao, N. (2024). Central serous chorioretinopathy and the sclera: what we have learned so far. Japanese Journal of Ophthalmology, 68(5), 419-428. https://doi.org/10.1007/s10384-024-01101-2
Lahousen, T., Painold, A., Luxenberger, W., Schienle, A., Kapfhammer, H. P., & Ille, R. (2016). Psychological factors associated with acute and chronic central serous chorioretinopathy. Nordic Journal of Psychiatry, 70(1), 24-30. https://doi.org/10.3109/08039488.2015.1041156
Lang, P. J., McTeague, L. M., & Bradley, M. M. (2016). RDoC, DSM, and the reflex physiology of fear: A biodimensional analysis of the anxiety disorders spectrum. Psychophysiology, 53(3), 336-347. https://doi.org/10.1111/psyp.12462
Lei, A. A., Phang, V. W. X., Lee, Y. Z., Kow, A. S. F., Tham, C. L., Ho, Y. C., & Lee, M. T. (2025). Chronic Stress-Associated Depressive Disorders: The Impact of HPA Axis Dysregulation and Neuroinflammation on the Hippocampus—A Mini Review. International Journal of Molecular Sciences, 26(7), 2940. https://doi.org/10.3390/ijms26072940
Liang, Z. Q., Huang, L. Z., Qu, J. F., & Zhao, M. W. (2018). Association between endogenous cortisol level and the risk of central serous chorioretinopathy: a Meta-analysis. International Journal of Ophthalmology, 11(2), 296. https://doi.org/10.18240/ijo.2018.02.19
Liew, G., Quin, G., Gillies, M., & Fraser‐Bell, S. (2013). Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clinical & experimental ophthalmology, 41(2), 201-214. https://doi.org/10.1111/j.1442-9071.2012.02848.x
Liu, B., Deng, T., & Zhang, J. (2016). Risk factors for central serous chorioretinopathy: a systematic review and meta-analysis. Retina, 36(1), 9-19. https://doi.org/10.1097/IAE.0000000000000837
Lotery, A. (2022). Can we classify central serous chorioretinopathy better? Yes we can. Eye, 36(3), 487-487. https://doi.org/10.1038/s41433-021-01786-6
Mansour, A. M., Koaik, M., Lima, L. H., Casella, A. M. B., Uwaydat, S. H., Shahin, M., Tamin, H., Sanchez-Ruiz, S., Mansour, H. A., & Dodwell, D. (2017). Physiologic and psychologic risk factors in central serous chorioretinopathy. Ophthalmology Retina, 1(6), 497-507. https://doi.org/10.1016/j.oret.2017.02.009
Mathews, R., Horo, S., Jose, D., Kavalakatt, J. A., & John, S. S. (2023). Role of Psychological Stress and Choroidal Thickness in Central Serous Chorioretinopathy. Nepalese Journal of Ophthalmology, 15(2), 36-46. https://doi.org/10.3126/nepjoph.v15i2.53598
Mukherji, S., Karmakar, S., & Dasgupta, S. (2024). Association of central serous chorioretinopathy with type of personality, anxiety and depression. Indian Journal of Ophthalmology, 72(Suppl 1), S60-S65. https://doi.org/10.4103/IJO.IJO_1180_23
Mylona, I., Dermenoudi, M., Tsinopoulos, I., & Floros, G. (2022). Personality of patients with central serous chorioretinopathy. European Journal of Ophthalmology, 32(1), 497-500. https://doi.org/10.1177/1120672120968763
Nunez, S. G., Rabelo, S. P., Subotic, N., Caruso, J. W., & Knezevic, N. N. (2025). Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation. International journal of molecular sciences, 26(20), 9994. https://doi.org/10.3390/ijms26209994
Parshoeva, L. S., Asylkhuzina, D. S., Podkopaeva, D. P., Murtazina, R. T., Siriev, K. A., Neibauer, A. S., Klimenkova, M. R., Timan, A. G., Abilgasanli, A. Y., & Kotykhova, A. I. (2024). Features of ophthalmological pathologies that occur against the background of neuropsychiatric disorders. Cardiometry, (31), 127-131. https://doi.org/10.18137/cardiometry.2024.31.127131
Piskunowicz, M., Jaracz, M., Lesiewska, H., Malukiewicz, G., Brożek-Pestka, M., & Borkowska, A. (2014). Temperament profile in patients with central serous chorioretinopathy: a case-control study. European Journal of Ophthalmology, 24(3), 392-395. https://doi.org/10.5301/ejo.5000377
Preti, A., Vellante, M., Zucca, G., Tondo, L., Akiskal, K., & Akiskal, H. (2010). The Italian version of the validated short TEMPS-A: the temperament evaluation of Memphis, Pisa, Paris and San Diego. Journal of affective disorders, 120(1-3), 207-212. https://doi.org/10.1016/j.jad.2009.02.025
Reeves, J. W., Fisher, A. J., Newman, M. G., & Granger, D. A. (2016). Sympathetic and hypothalamic‐pituitary‐adrenal asymmetry in generalized anxiety disorder. Psychophysiology, 53(6), 951-957. https://doi.org/10.1111/psyp.12634
Sahoo, N. K., Ong, J., Selvam, A., Brown, R., Avdalimov, M., Kulkarni, A., Hansraj, S., Gujar, R., Lupidi, M., Zur, D., & Chhablani, J. (2024). Gender differences in central serous chorioretinopathy based on the new multimodal imaging classification. Eye, 38(5), 964-967. https://doi.org/10.1038/s41433-023-02812-5
Scarinci, F., Ghiciuc, C. M., Patacchioli, F. R., Palmery, M., & Parravano, M. (2019). Investigating the hypothesis of stress system dysregulation as a risk factor for central serous chorioretinopathy: a literature mini-review. Current Eye Research, 44(6), 583-589. https://doi.org/10.1080/02713683.2019.1565891
Scarinci, F., Patacchioli, F. R., Costanzo, E., & Parravano, M. (2022). Cortisol awake response imbalance as an indicator of acute central serous chorioretinopathy: Relationship with choriocapillaris and choroidal features. Frontiers in Medicine, 9, 1030352. https://doi.org/10.3389/fmed.2022.1030352
Sesar, A. P., Sesar, A., Bucan, K., Sesar, I., Cvitkovic, K., & Cavar, I. (2021). Personality traits, stress, and emotional intelligence associated with central serous chorioretinopathy. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 27, e928677-1. https://doi.org/10.12659/MSM.928677
Sesar, A., Sesar, A. P., Jurisic, D., Cvitkovic, K., & Cavar, I. (2023). Unraveling the puzzle of central serous chorioretinopathy: exploring psychological factors and pathophysiological mechanisms. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 29, e941216-1. https://doi.org/10.12659/MSM.941216
Sharma, A., Bhanu, B., & Raveendra, T. (2022). Influence of Professional Status and Psychological State in Development of Central Serous Chorioretinopathy, and it's Response to Treatment Outcome. Retina-Vitreus/Journal of Retina-Vitreous, 31(3). https://doi.org/10.37845/ret.vit.2022.31.40
Smart, R. G. (1964). The importance of negative results in psychological research. Canadian Psychologist/Psychologie Canadienne, 5(4), 225. https://doi.org/10.1037/h0083036
Spaide, R. F., Fisher, Y. L., Ngo, W. K., & Barbazetto, I. (2022). Regional scleral thickness as a risk factor for central serous chorioretinopathy. Retina, 42(7), 1231-1237. https://doi.org/10.1097/IAE.0000000000003485
Stokes, P. E. (2019). The neuroendocrinology of anxiety. Anxiety and the anxiety disorders, 53-76. https://doi.org/10.4324/9780203728215-5
Tillmann, A., Ceklic, L., Dysli, C., & Munk, M. R. (2024). Gender differences in retinal diseases: A review. Clinical & experimental ophthalmology, 52(3), 317-333. https://doi.org/10.1111/ceo.14364
Tolin, D. F., Lee, E., Levy, H. C., Das, A., Mammo, L., Katz, B. W., & Diefenbach, G. J. (2021). Psychophysiological assessment of stress reactivity and recovery in anxiety disorders. Journal of Anxiety Disorders, 82, 102426. https://doi.org/10.1016/j.janxdis.2021.102426
van Haalen, F. M., van Dijk, E. H., Savas, M., Brinks, J., Dekkers, O. M., Dijkman, G., van Rossum, E. F. C., Biermasz, N. R., Boon, C. J. F., & Pereira, A. M. (2020). Hair cortisol concentrations in chronic central serous chorioretinopathy. Acta Ophthalmologica, 98(4), 390-395. https://doi.org/10.1111/aos.14269
Weintraub, P. G. (2016). The importance of publishing negative results. Journal of Insect Science, 16(1), 109. https://doi.org/10.1093/jisesa/iew092
Yoneyama, S., Fukui, A., Sakurada, Y., Terao, N., Shijo, T., Kusada, N., Sugiyama, A., Matsubara, M., Fukuda, Y., Kikushima, W., Parikh, R., Mabuchi, F., Sotozono, C., & Kashiwagi, K. (2022). Distinct characteristics of central serous chorioretinopathy according to gender. Scientific Reports, 12(1), 10565. https://doi.org/10.1038/s41598-022-14777-8
Zarnegar, A., Ong, J., Matsyaraja, T., Arora, S., & Chhablani, J. (2023). Pathomechanisms in central serous chorioretinopathy: A recent update. International Journal of Retina and Vitreous, 9(1), 3. https://doi.org/10.1186/s40942-023-00443-2
Zigiotti, G. L., Cavarretta, S., Morara, M., Nam, S. M., Ranno, S., Pichi, F., Lembo, A., Lupo, S., Nucci, P., & Meduri, A. (2012). Standard Enucleation with Aluminium Oxide Implant (Bioceramic) Covered with Patient′ s Sclera. The Scientific World Journal, 2012(1), 481584. https://doi.org/10.1100/2012/481584
DOI: https://doi.org/10.13129/2282-1619/mjcp-5120
Refbacks
- There are currently no refbacks.